Rapp, Felicitas http://orcid.org/0000-0003-0968-1546
Simoniello, Palma http://orcid.org/0000-0003-2888-2642
Wiedemann, Julia
Bahrami, Karola http://orcid.org/0000-0001-9911-1875
Grünebaum, Valeria http://orcid.org/0000-0003-4568-8227
Ktitareva, Svetlana http://orcid.org/0000-0002-7098-4442
Durante, Marco http://orcid.org/0000-0002-4615-553X
Lugenbiel, P.
Thomas, D.
Lehmann, H. Immo http://orcid.org/0000-0003-4379-283X
Packer, Douglas L.
Graeff, Christian http://orcid.org/0000-0002-5296-7649
Fournier, Claudia http://orcid.org/0000-0002-1007-9934
Article History
Received: 12 October 2018
Accepted: 26 February 2019
First Online: 21 March 2019
Competing Interests
: Dr. D. Packer in the past 12 months has provided consulting services for Abbott $0, Aperture Diagnostics, Biosense Webster $0, Inc., Biotronik < $5000, Boston Scientific $0, CardioFocus $0, Johnson & Johnson $0, MediaSphere Medical, LLC, Medtronic $0, St. Jude Medical, and Siemens $0, SigNum Preemptive Healthcare, Inc., Spectrum Dynamics $0, and Thermedical $0. Dr. Packer receives research funding from the Abbott, Biosense Webster, Boston Scientific/EPT, CardioInsight, CardioFocus, Endosense, Hansen Medical, Medtronic, NIH, Robertson Foundation, St. Jude Medical, Siemens and Thermedical. Mayo Clinic and Dr. D. Packer have a financial interest in mapping technology. In accordance with the Bayh-Dole Act, this technology has been licensed to St. Jude Medical, and Mayo Clinic and Dr. Packer have received annual royalties greater than $10,000, the federal threshold for significant financial interest. Dr. Packer and Mayo Clinic jointly have equity in a privately held company, External Beam Ablation Medical Devices. Royalties from Wiley & Sons, Oxford, and St. Jude Medical. Dr. D. Thomas reports receiving lecture fees/honoraria from Bayer Vital, Boehringer Ingelheim Pharma, Bristol-Myers Squibb, Daiichi Sankyo, Medtronic, Pfizer Pharma, Sanofi-Aventis, St. Jude Medical and ZOLL CMS. The other authors declare no competing interests.